HRT Financial’s Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 PIAI.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-33,352
Closed -$1K 3381
2023
Q2
$1K Hold
33,352
﹤0.01% 2348
2023
Q1
$1K Sell
33,352
-100
-0.3% -$6 ﹤0.01% 2400
2022
Q4
$0 Buy
33,452
+100
+0.3% +$2 ﹤0.01% 3468
2022
Q3
$2K Buy
+33,352
New +$1.64K ﹤0.01% 2662

HRT Financial's PIAI.WS Position: Q3 2023 in Review

HRT Financial sold out of Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (PIAI.WS) in Q3 2023, closing a stake of 33,352 shares — an estimated $1K sold.

HRT Financial first reported a position in PIAI.WS in Q3 2022 and held it in 4 quarters. The position peaked at $2K in Q3 2022. 0 funds tracked by Wall St. Rank hold PIAI.WS as of Q3 2023.

  • HRT Financial reported no remaining Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 33,352 Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2023, an estimated $1K.
  • HRT Financial first reported a position in Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2022 and held it in 4 quarters.
  • HRT Financial's Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $2K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Prime Impact Acquisition I Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.